Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating the anti-CEACAM5 antibody-drug conjugate M9140 in adults with advanced solid tumors, including gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• M9140

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Solid Tumors, Gastric Cancer | Phase 1, Phase 2 | Status: RECRUITING